Home-based #Exercise Improves #Muscle #Oxidative Capacity in #Kidney #Disease #VisualAbstract by Husam Alzayer https://www.kireports.org/article/S2468-0249(25)00755-7/fulltext Gwenaelle Begue Armin Ahmadi, PhD Bob Roshanravan

A study in #ASNKidney360 finds that tubule biomarkers may reveal microvascular pathways linking kidney dysfunction to cardiovascular risk beyond eGFR or ACR. Check it out: kidney.pub/KID0970#ASNKidney360 @arahmadi.bsky.social

Recent publication by LAUNCH affiliate @arahmadi.bsky.social and alumnus Heiko Yang: Packed Red Blood Cell and Whole Blood Perfusates during Ex-Vivo Normothermic Perfusion for Assessment of High-Risk Donor Kidneys. Congrats Armin and Heiko! pubmed.ncbi.nlm.nih.gov/40333014/ @broshanr.bsky.social

Compared to WB, PRBC perfusion is superior in mitigating post-ischemia damage and facilitating function and metabolic recovery of high-risk kidneys subjected to long CITs during a three-hour EVNP. https://bit.ly/KID0815 #ASNKidney360 @arahmadi.bsky.social @broshanr.bsky.social

NIH research saves lives and powers the economy. In California, it supports ~56K jobs and $13.55B in economic activity. Cuts to NIH funding puts lives and livelihoods in jeopardy. Congress must act—tell your lawmakers to save medical research funding now! ucdav.is/4i4zFfB #SaveNIHresearch

Machine Perfusion in Deceased Donor Kidney Transplantation: Editorial Summary of a Cochrane Review by @samjtingle.bsky.social and Colin Hugh Wilson https://bit.ly/AJKD25TingleCCS (FREE)

Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials https://bit.ly/42Hkwwh #OpenAccess #VisualAbstract

Incretins are regulators of insulin secretion and glucose homeostasis metabolized by DPP-4. This study found that incretin response to oral glucose is preserved or augmented in moderate-to-severe CKD, without apparent differences in circulating DPP-4 concentration or activity. bit.ly/CJASN0566

bit.ly/CJASN0624 @arahmadi.bsky.social @kidney-resrch-inst.bsky.social

Our randomized crossover trial of nicotinamide riboside (NR) and co-enzyme Q10 (CoQ10) in sedentary patients with chronic kidney disease (CKD) is now published in CJASN. Read the full article:https://journals.lww.com/cjasn/abstract/9900/a_pilot_trial_of_nicotinamide_riboside_and.533.aspx#

Impaired Incretin Homeostasis in Nondiabetic... : Clinical Journal of the American Society of Nephrology journals.lww.com/cjasn/fullte...